Revance Therapeutics, Inc.

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
DaxibotulinumtoxinA for Blepharospasm	Dyskinesias, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, basal ganglia disorder, benign essential blepharospasm, brain disorder, central nervous system disorder, dystonic disorder, eye disorder, eyelid disorder, movement disorder, nervous system disorder, parkinsonian disorder	Recruiting	Phase 2	2026-09-29		NCT07489430
Effects of DaxibotulinumtoxinA for Blepharospasm and Hemifacial Spasm	Hemifacial Spasm, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Spasm, Stomatognathic Diseases, benign essential blepharospasm, mouth disorder, nervous system disorder	Recruiting	Phase 4	2026-04-23		NCT06195241

Clinical trials